Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$209.01 - $232.56 $1.34 Million - $1.49 Million
6,409 Added 2.88%
229,132 $50.1 Million
Q4 2023

Feb 13, 2024

BUY
$197.69 - $227.29 $422,265 - $485,491
2,136 Added 0.97%
222,723 $50.6 Million
Q3 2023

Nov 14, 2023

SELL
$201.05 - $221.7 $113,593 - $125,260
-565 Reduced 0.26%
220,587 $44.3 Million
Q2 2023

Aug 14, 2023

SELL
$211.93 - $241.33 $357,102 - $406,641
-1,685 Reduced 0.76%
221,152 $53.4 Million
Q1 2023

May 15, 2023

SELL
$213.32 - $257.83 $71,675 - $86,630
-336 Reduced 0.15%
222,837 $51.1 Million
Q4 2022

Feb 10, 2023

BUY
$203.72 - $248.97 $244,667 - $299,012
1,201 Added 0.54%
223,173 $52.5 Million
Q3 2022

Nov 14, 2022

BUY
$204.81 - $262.19 $560,360 - $717,351
2,736 Added 1.25%
221,972 $45.5 Million
Q2 2022

Aug 12, 2022

BUY
$213.86 - $277.87 $628,748 - $816,937
2,940 Added 1.36%
219,236 $51.4 Million
Q1 2022

May 16, 2022

SELL
$259.82 - $298.18 $147,837 - $169,664
-569 Reduced 0.26%
216,296 $57 Million
Q4 2021

Feb 14, 2022

BUY
$271.6 - $314.21 $520,385 - $602,026
1,916 Added 0.89%
216,865 $68.1 Million
Q3 2021

Nov 15, 2021

SELL
$274.82 - $308.34 $223,978 - $251,297
-815 Reduced 0.38%
214,949 $60.5 Million
Q2 2021

Aug 16, 2021

SELL
$251.87 - $278.14 $285,620 - $315,410
-1,134 Reduced 0.52%
215,764 $59.5 Million
Q1 2021

May 14, 2021

SELL
$204.88 - $255.03 $10,858 - $13,516
-53 Reduced 0.02%
216,898 $55.3 Million
Q4 2020

Feb 16, 2021

BUY
$186.91 - $214.42 $263,169 - $301,903
1,408 Added 0.65%
216,951 $44.2 Million
Q3 2020

Nov 16, 2020

SELL
$167.03 - $201.3 $1.44 Million - $1.74 Million
-8,633 Reduced 3.85%
215,543 $40.6 Million
Q2 2020

Aug 14, 2020

SELL
$113.31 - $182.44 $253,587 - $408,300
-2,238 Reduced 0.99%
224,176 $37.2 Million
Q1 2020

May 13, 2020

SELL
$104.32 - $195.28 $351,141 - $657,312
-3,366 Reduced 1.46%
226,414 $28.6 Million
Q4 2019

Feb 12, 2020

BUY
$163.48 - $173.61 $292,629 - $310,761
1,790 Added 0.79%
229,780 $38.9 Million
Q3 2019

Nov 14, 2019

BUY
$159.77 - $178.1 $143,793 - $160,290
900 Added 0.4%
227,990 $38.3 Million
Q2 2019

Aug 14, 2019

BUY
$144.16 - $172.9 $621,041 - $744,853
4,308 Added 1.93%
227,090 $39.3 Million
Q1 2019

May 14, 2019

BUY
$123.7 - $156.3 $27.6 Million - $34.8 Million
222,782 New
222,782 $34.1 Million

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $22.1B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Fairview Capital Investment Management, LLC Portfolio

Follow Fairview Capital Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fairview Capital Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fairview Capital Investment Management, LLC with notifications on news.